Phase 1Data readout

ZL-6201 (LRRC15 ADC)

Sarcoma And Selected Tumors

ZLABZai Lab

Expected catalystJune 30, 2027Company guidance: Jun 30, 2027

Catalyst overview

Event details

Drug or asset: ZL-6201 (LRRC15 ADC)
Development stage: Phase 1
Event type: Data readout
Indication: Sarcoma And Selected Tumors

Research summary

What is being tracked?

This catalyst tracks a Phase 1 data readout for ZL-6201 (LRRC15 ADC) in Sarcoma And Selected Tumors. The expected timing is based on the latest available company guidance and may change.

Development notes

08/06/26:- Phase 1a/b dose-escalation topline results expected H1 2027.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

ZL-6201 (LRRC15 ADC)

Event details

What is being tracked?

Development notes

Primary source

Related pipeline programs

Povetacicept (Pove) (APRIL/BAFF Inhibitor)

VYVGART/Efgartigimod Alfa (FcRn Blocker)

ZL-1503

Zocilurtatug pelitecan (formerly ZL-1310)